Your A-Z of episodes

Did you know there’s even more we can do to promote your episode? Find out more…

  • Episode 263

    From big pharma manufacturing lead to CDMO CEO

    Joerg Ahlgrimm

    / SK pharmteco

    Joerg Ahlgrimm, CEO of SK pharmteco talks about his 25+ years experience in building and managing CDMO relationships.

  • Episode 262

    M2M Pulse: 7 Trends CDMO You Can’t Ignore

    Raman Sehgal

    / Molecule To Market

    Our host Raman Sehgal talks about 7 trends that CDMOs should not ignore in 2026. The final instalment of the Pulse Survey Series.

  • Episode 261

    25+ years & 200+ deals – meet the prolific pharma dealmaker

    Banks Bourne

    / Bourne Partners

    Banks Bourne, Founder & Chief Executive Officer at Bourne Partners talks about his experience investing in the right place at the right time.

  • Episode 260

    The 30-year, overnight success

    Julian Casciano

    / eMAX Health

    Julian Casciano, President & CEO at eMAX Health talks about how his personal experience shaped his path into healthcare.

  • Episode 259

    The CDMO CEO Operator Playbook for 2026

    Raman Sehgal

    / Molecule To Market

    Our host Raman Sehgal talks about the internal challenges and biggest opportunities CDMO CEOs face in 2026.

  • Episode 258

    The AI CEO changing pharma from the inside

    Pep Gubau

    / Aizon

    Pep Gubau, CEOm, CTO & Co-Founder at Aizon talks about the role that AI plays in the pharma manufacturing industry.

  • Episode 257

    CDMO & C-suite headwinds for 2026

    Raman Sehgal

    / Molecule to Market

    Our host Raman Sehgal talks about the big headwinds for the pharmaceutical and biotechnology space for 2026.

  • Episode 256

    Insights from JPM

    Catherine Hunter, Chris Garabedian & Dean McAlister

    / ramarketing, Xontogeny & Inizio Biotech

    Our host discusses with three senior leaders on their insights from The JPM’s Annual Healthcare Conference 2026.

  • Episode 255

    CDMO C-suite optimism pulse for 2026

    Raman Sehgal

    / Molecule to Market

    Our host Raman Sehgal summarises predictions from CDMO C-suite leaders for the pharmaceutical and biotechnology space for 2026.

  • Episode 254

    The AI entrepreneur fighting against cancer

    Selin Kurnaz

    / Massive Bio

    Selin Kurnaz, Co-Founder & CEO of Massive Bio talks about the role of AI in drug development and her entrepreneurial journey.

  • Load more